Praxis Precision Medicines, Inc. PRAX
280.78
(1.01)
(0.36%)
as of 25 Sep
- Market cap
- $7.9B
- P/E
- 0.0×
Follow PRAX
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | 0.00 | 0.00 | — | — | — | — | — | — |
P/S ratio |
— | 161.13 | 56.32 | — | — | — | — | — | — |
P/FCF ratio |
— | 0.00 | 0.00 | — | — | — | — | — | — |
P/Operating CF |
— | (24.56) | (5.78) | — | — | — | — | — | — |
P/B ratio |
— | 3.09 | 1.98 | — | — | — | — | — | — |
Price to Tangible BV |
— | 3.09 | 1.98 | — | — | — | — | — | — |
EV/Sales |
— | 115.23 | 23.10 | — | — | — | — | — | — |
EV/EBITDA |
— | 0.00 | 0.00 | — | — | — | — | — | — |
EV/Operating CF |
— | (7.48) | (0.51) | — | — | — | — | — | — |
EV/FCF |
— | (7.47) | (0.51) | — | — | — | — | — | — |
Quick Ratio |
10.03 | 10.45 | 5.16 | 2.93 | 7.18 | 18.87 | 6.57 | 3.49 | — |
Current Ratio |
10.22 | 10.77 | 5.39 | 3.23 | 7.48 | 19.23 | 6.67 | 3.72 | — |
Net Debt/EBITDA |
1.82 | 1.92 | 0.65 | 0.47 | 1.67 | 4.79 | 1.25 | 0.79 | — |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Asset Turnover |
0.00 | 0.03 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
0.82 | 0.72 | 0.90 | 0.86 | 0.75 | 0.75 | 0.82 | 0.71 | — |
Capex/Depreciation |
0.02 | 0.00 | (0.10) | (0.31) | (0.46) | 0.00 | (2.78) | (63.00) | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| (45.83%) | (70.98%) | (169.13%) | (130.94%) | (62.07%) | (68.13%) | 66.67% | 47.89% | — | |
| (42.68%) | (64.03%) | (121.41%) | (104.95%) | (56.07%) | (40.08%) | (120.50%) | (294.75%) | — | |
ROIC |
(73.12%) | (236.57%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Return on Tangible Assets |
(55.01%) | (49.81%) | (176.82%) | (276.29%) | (66.77%) | (24.53%) | (104.83%) | (207.49%) | — |
Average Days of Receivables |
— | 0.00 | 0.00 | — | — | — | — | — | — |
Research and Development Expense of Revenue |
0.00% | 1,781.98% | 3,545.81% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Selling, General and Administrative Expense of Revenue |
0.00% | 658.31% | 1,718.59% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 483.57% | 1,015.82% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Graham Net Nets |
— | 0.27 | 0.48 | — | — | — | — | — | — |
Graham Number |
— | 0.00 | 0.00 | — | — | — | — | — | — |
Earnings Yield |
— | (13.34%) | (113.21%) | — | — | — | — | — | — |
Free Cash Flow Yield |
— | (9.58%) | (80.79%) | — | — | — | — | — | — |
Revenue per Share |
0.00 | 0.48 | 0.37 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF per Share |
(11.07) | (7.36) | (16.85) | (60.22) | (43.99) | (88.15) | (327.33) | (239.27) | — |
Capex per Share |
0.00 | 0.00 | (0.01) | (0.14) | (0.37) | 0.00 | (1.01) | (0.73) | — |
Free Cash Flow per Share |
(11.07) | (7.36) | (16.86) | (60.36) | (44.36) | (88.15) | (328.33) | (240.00) | — |
Cash per Share |
26.63 | 21.92 | 12.33 | 32.70 | 97.44 | 496.83 | 438.93 | 207.27 | — |
Shareholders Equity per Share |
39.02 | 24.88 | 10.57 | 24.77 | 88.57 | 481.50 | (793.42) | (473.88) | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
39.02 | 24.88 | 10.57 | 24.77 | 88.57 | 481.50 | (793.42) | (473.88) | — |
Free Cash Flow |
(249.12) | (131.76) | (111.19) | (185.49) | (125.60) | (52.62) | (33.52) | (20.78) | — |
Working Capital |
551.14 | 366.82 | 69.13 | 76.50 | 248.98 | 286.61 | 38.68 | 13.98 | — |
Capital Expenditures |
(0.06) | — | (0.05) | (0.44) | (1.05) | — | (0.10) | (0.06) | — |
Net Current Asset Value |
551.14 | 366.71 | 66.60 | 71.82 | 245.47 | 286.61 | (83.21) | (41.74) | — |
EV/EBIT |
— | 0.00 | 0.00 | — | — | — | — | — | — |
Capex to Sales |
0.00 | 0.00 | 0.02 | 0.00 | 0.00 | — | 0.00 | 0.00 | — |
Net Profit Margin |
0.00% | (2,137.48%) | (5,037.88%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Price to Operating Income |
— | 0.00 | 0.00 | — | — | — | — | — | — |
| Other line items | |||||||||
Depreciation/Fixed assets |
(23.48) | (20.23) | 0.81 | 1.46 | 1.87 | 0.61 | 0.29 | 0.01 | — |
Cash ROIC |
(16.87%) | (15.75%) | (74.00%) | (105.33%) | (23.88%) | (9.02%) | 92.69% | 90.19% | — |
Accounts Receivable Turnover |
— | 0.00 | 0.00 | — | — | — | — | — | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Payables |
18.58 | 9.17 | 10.24 | 12.73 | 7.43 | 3.38 | 3.03 | 3.03 | — |
Average Assets |
710.51 | 285.53 | 101.54 | 203.94 | 297.96 | 175.44 | 33.76 | 9.91 | — |
Average Common Equity |
661.79 | 257.56 | 72.89 | 163.46 | 269.13 | 103.22 | (61.02) | (61.02) | — |
Columns are period end dates